Acute bilateral central serous chorioretinopathy in a young male after the first dose of Oxford/AstraZeneca AZD1222 (Covishield) vaccine

We case of acute bilateral central serous chorioretinopathy (CSCR) after receiving the first dose of Covishield vaccine in a young, otherwise healthy male with no associated risk factors.

Detalles Bibliográficos
Autores principales: Sindhu, Meenakshi, Bamotra, Ravi Kant, Singh, Sukhdev
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228969/
https://www.ncbi.nlm.nih.gov/pubmed/36727385
http://dx.doi.org/10.4103/ijo.IJO_1629_22
_version_ 1785051107600367616
author Sindhu, Meenakshi
Bamotra, Ravi Kant
Singh, Sukhdev
author_facet Sindhu, Meenakshi
Bamotra, Ravi Kant
Singh, Sukhdev
author_sort Sindhu, Meenakshi
collection PubMed
description We case of acute bilateral central serous chorioretinopathy (CSCR) after receiving the first dose of Covishield vaccine in a young, otherwise healthy male with no associated risk factors.
format Online
Article
Text
id pubmed-10228969
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-102289692023-05-31 Acute bilateral central serous chorioretinopathy in a young male after the first dose of Oxford/AstraZeneca AZD1222 (Covishield) vaccine Sindhu, Meenakshi Bamotra, Ravi Kant Singh, Sukhdev Indian J Ophthalmol Case Reports We case of acute bilateral central serous chorioretinopathy (CSCR) after receiving the first dose of Covishield vaccine in a young, otherwise healthy male with no associated risk factors. Wolters Kluwer - Medknow 2023-02 2023-02-02 /pmc/articles/PMC10228969/ /pubmed/36727385 http://dx.doi.org/10.4103/ijo.IJO_1629_22 Text en Copyright: © 2023 Indian Journal of Ophthalmology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Case Reports
Sindhu, Meenakshi
Bamotra, Ravi Kant
Singh, Sukhdev
Acute bilateral central serous chorioretinopathy in a young male after the first dose of Oxford/AstraZeneca AZD1222 (Covishield) vaccine
title Acute bilateral central serous chorioretinopathy in a young male after the first dose of Oxford/AstraZeneca AZD1222 (Covishield) vaccine
title_full Acute bilateral central serous chorioretinopathy in a young male after the first dose of Oxford/AstraZeneca AZD1222 (Covishield) vaccine
title_fullStr Acute bilateral central serous chorioretinopathy in a young male after the first dose of Oxford/AstraZeneca AZD1222 (Covishield) vaccine
title_full_unstemmed Acute bilateral central serous chorioretinopathy in a young male after the first dose of Oxford/AstraZeneca AZD1222 (Covishield) vaccine
title_short Acute bilateral central serous chorioretinopathy in a young male after the first dose of Oxford/AstraZeneca AZD1222 (Covishield) vaccine
title_sort acute bilateral central serous chorioretinopathy in a young male after the first dose of oxford/astrazeneca azd1222 (covishield) vaccine
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228969/
https://www.ncbi.nlm.nih.gov/pubmed/36727385
http://dx.doi.org/10.4103/ijo.IJO_1629_22
work_keys_str_mv AT sindhumeenakshi acutebilateralcentralserouschorioretinopathyinayoungmaleafterthefirstdoseofoxfordastrazenecaazd1222covishieldvaccine
AT bamotraravikant acutebilateralcentralserouschorioretinopathyinayoungmaleafterthefirstdoseofoxfordastrazenecaazd1222covishieldvaccine
AT singhsukhdev acutebilateralcentralserouschorioretinopathyinayoungmaleafterthefirstdoseofoxfordastrazenecaazd1222covishieldvaccine

Ejemplares similares